These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11889266)

  • 1. Frequency of bowel movements and future risk of Parkinson's disease.
    Lesser GT
    Neurology; 2002 Mar; 58(5):838; author reply 838-9. PubMed ID: 11889266
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural toxin implicated as triggering Parkinson's disease.
    Pak J Biol Sci; 2011 Feb; 14(3):255. PubMed ID: 21870660
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic and environmental factors in the pathogenesis of Parkinson's disease.
    Mizuno Y; Shimoda-Matsubayashi S; Matsumine H; Morikawa N; Hattori N; Kondo T
    Adv Neurol; 1999; 80():171-9. PubMed ID: 10410718
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic Parkinson's disease: a genetic and environmental model.
    Williams AC; Smith ML; Waring RH; Ramsden DB
    Adv Neurol; 1999; 80():215-8. PubMed ID: 10410724
    [No Abstract]   [Full Text] [Related]  

  • 5. Life style risks of Parkinson's disease: association between decreased water intake and constipation.
    Ueki A; Otsuka M
    J Neurol; 2004 Oct; 251 Suppl 7():vII18-23. PubMed ID: 15505750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease?
    Collins MA; Neafsey EJ; Matsubara K; Cobuzzi R; Albores R; Fields J; Rollema H
    Ann N Y Acad Sci; 1992 May; 648():263-5. PubMed ID: 1637053
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the environment in Parkinson's disease.
    Gorrell JM; DiMonte D; Graham D
    Environ Health Perspect; 1996 Jun; 104(6):652-4. PubMed ID: 8793354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neurotoxin candidates as pathogenic agents of Parkinson's disease].
    Naoi M
    No To Shinkei; 1997 Sep; 49(9):793-803. PubMed ID: 9310995
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotoxicity and neuroprotection in Parkinson's disease.
    Lange KW; Youdim MB; Riederer P
    J Neural Transm Suppl; 1992; 38():27-44. PubMed ID: 1491247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of bowel movements and the future risk of Parkinson's disease.
    Abbott RD; Petrovitch H; White LR; Masaki KH; Tanner CM; Curb JD; Grandinetti A; Blanchette PL; Popper JS; Ross GW
    Neurology; 2001 Aug; 57(3):456-62. PubMed ID: 11502913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental models, of Parkinson disease].
    Luquin MR
    Rev Neurol; 2000 Jul 1-15; 31(1):60-6. PubMed ID: 10948587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of Parkinson's disease: an update].
    Tremblay L
    Bull Acad Natl Med; 2010 Oct; 194(7):1321-31; discussion 1331-2. PubMed ID: 22043627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
    Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?
    Vandervort WJ
    Del Med J; 1987 Aug; 59(8):533-4, 537. PubMed ID: 3666247
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parkinson's disease--the molecular mechanism].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1341-52. PubMed ID: 1972586
    [No Abstract]   [Full Text] [Related]  

  • 16. Current theories on the cause of Parkinson's disease.
    Langston JW
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):13-7. PubMed ID: 2666574
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of swallowing and defecation in Parkinson's disease.
    Edwards LL; Quigley EM; Harned RK; Hofman R; Pfeiffer RF
    Am J Gastroenterol; 1994 Jan; 89(1):15-25. PubMed ID: 8273792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology and pathogenesis of Parkinson's disease.
    Olanow CW; Tatton WG
    Annu Rev Neurosci; 1999; 22():123-44. PubMed ID: 10202534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological models of Parkinson's disease in rodents.
    Klivenyi P; Vecsei L
    Methods Mol Biol; 2011; 793():211-27. PubMed ID: 21913103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure to n-hexane contributes to induce onset of Parkinson's disease.
    Qing-Shan W; Ke-Qin X
    Med Hypotheses; 2009 Jan; 72(1):107-8. PubMed ID: 18801623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.